LYEL Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-11-13S-30001193125-26-460585SEC →
2026-11-1240002095702-26-000007SEC →
2026-11-1240001907345-26-000008SEC →
2026-11-1240001866154-26-000008SEC →
2026-11-1240001327111-26-000008SEC →
2026-11-10SCHEDULE 13G/A0001012975-26-001025SEC →
2026-11-0540001012975-26-001014SEC →
2026-11-0540001012975-26-001013SEC →
2026-11-0410-Q0001628280-26-070171SEC →
2026-11-048-K0001628280-26-070161SEC →
2026-11-048-K0001193125-26-446317SEC →
2026-10-1340002150331-26-000003SEC →
2026-09-1040002150331-26-000002SEC →
2026-09-1030002150331-26-000001SEC →
2026-09-1040001959742-26-000003SEC →
2026-09-108-K0001193125-26-387890SEC →
2026-08-2540001907345-26-000006SEC →
2026-08-2540001866154-26-000006SEC →
2026-08-2540001327111-26-000006SEC →
2026-08-14SCHEDULE 13G/A0001104659-26-097073SEC →
2026-08-1140002095702-26-000005SEC →
2026-08-1140001907345-26-000004SEC →
2026-08-1140001866154-26-000004SEC →
2026-08-1140001327111-26-000004SEC →
2026-08-0610-Q0001628280-26-054367SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Lyell Immunopharma (LYEL) — Filings